过继免疫治疗
生物
细胞毒性T细胞
免疫学
过继性细胞移植
效应器
癌症免疫疗法
免疫疗法
T细胞
癌症研究
抗原提呈细胞
免疫
白细胞介素21
记忆T细胞
免疫系统
白细胞介素12
细胞生物学
白细胞介素15
白细胞介素2受体
细胞培养
细胞疗法
细胞
细胞免疫
外周血单个核细胞
T淋巴细胞
癌症
作者
Julián A. Chamucero-Millares,David Andrés Bernal-Estévez,Carlos Parra-López
标识
DOI:10.1016/j.cellimm.2020.104257
摘要
Clonal anergy and depletion of antigen-specific CD8+ T cells are characteristics of immunosuppressed patients such as cancer and post-transplant patients. This has promoted translational research on the adoptive transfer of T cells to restore the antigen-specific cellular immunity in these patients. In the present work, we compared the capability of PBMCs and two types of mature monocyte-derived DCs (moDCs) to prime and to expand ex-vivo antigen-specific CD8+ T cells using culture conditioned media supplemented with IL-7, IL-15, and IL-21. The data obtained suggest that protocols involving moDCs are as efficient as PBMCs-based cultures in expanding antigen-specific CD8+ T cell to ELA and CMV model epitopes. These three gamma common chain cytokines promote the expansion of naïve-like and central memory CD8+ T cells in PBMCs-based cultures and the expansion of effector memory T cells when moDCs were used. Our results provide new insights into the use of media supplemented with IL-7, IL-15, and IL-21 for the in-vitro expansion of early-differentiated antigen-specific CD8+ T cells for immunotherapy purposes.
科研通智能强力驱动
Strongly Powered by AbleSci AI